145 related articles for article (PubMed ID: 8758772)
1. [The study of DNA fingerprint of hydatidiform moles and the clinical outcome].
Zhang X; Zhang L; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):203-5. PubMed ID: 8758772
[TBL] [Abstract][Full Text] [Related]
2. Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization.
Cheung AN; Sit AS; Chung LP; Ngan HY; O'Hanlan K; Wong LC; Ma HK
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):386-92. PubMed ID: 7835778
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor.
Lage JM; Berkowitz RS; Rice LW; Goldstein DP; Bernstein MR; Weinberg DS
Obstet Gynecol; 1991 Jan; 77(1):111-5. PubMed ID: 1845777
[TBL] [Abstract][Full Text] [Related]
4. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas.
Cheung AN; Srivastava G; Chung LP; Ngan HY; Man TK; Liu YT; Chen WZ; Collins RJ; Wong LC; Ma HK
J Reprod Med; 1994 Mar; 39(3):223-7. PubMed ID: 8035377
[TBL] [Abstract][Full Text] [Related]
5. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
Obstet Gynecol; 1994 Jan; 83(1):35-42. PubMed ID: 8272304
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluation of hydatidiform mole by DNA fingerprint method: the discrepancy in the diagnoses by pathological finding and the DNA fingerprint method.
Takahashi H; Ikarashi T; Kanazawa K; Kominami R; Tanaka K
Placenta; 1991; 12(5):487-93. PubMed ID: 1775442
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of cellular DNA and RNA contents of hydatidiform mole. Two significant parameters indicating malignant nature and prognosis.
Yin GP; Su YK
Chin Med J (Engl); 1993 Feb; 106(2):136-40. PubMed ID: 8389273
[TBL] [Abstract][Full Text] [Related]
8. Trophoblastic disease: clinical pathology of hydatidiform moles.
Szulman AE
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):443-56. PubMed ID: 3067170
[TBL] [Abstract][Full Text] [Related]
9. Malignant potential of homozygous and heterozygous complete moles.
Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric and clinicopathologic study of 197 hydatidiform moles with special reference to the significance of cytometric aneuploidy and literature review.
Fukunaga M; Endo Y; Ushigome S
Cytometry; 1995 Jun; 22(2):135-8. PubMed ID: 7587744
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative analysis of the cellular DNA and RNA contents of hydatidiform mole and its clinical significance].
Yin GP; Su YK; Zhuang GX
Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):538-41, 574. PubMed ID: 7835131
[TBL] [Abstract][Full Text] [Related]
12. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
13. A quantitative study of nuclear DNA of trophoblastic cells analysis of nuclear DNA distribution and clinical outcome of hydatidiform mole.
Kashimura Y
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):699-705. PubMed ID: 6864028
[TBL] [Abstract][Full Text] [Related]
14. Genetic origin analysis of hydatidiform mole and non-molar abortion using the polymerase chain reaction method.
Fujita N; Tamura S; Shimizu N; Nozawa S
Acta Obstet Gynecol Scand; 1994 Oct; 73(9):719-25. PubMed ID: 7976249
[TBL] [Abstract][Full Text] [Related]
15. Repeated gestational trophoblastic disease after natural and heterologous assisted conception. A case report.
Mangili G; Parazzini F; Maggi R; Spolti N
J Reprod Med; 1993 May; 38(5):405-6. PubMed ID: 8320682
[TBL] [Abstract][Full Text] [Related]
16. [HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].
Couillin P; Ravisé N; Afoutou JM; Chaïbi R; Azoulay M; Hors J; Oury JF; Boué J; Boué A
Ann Genet; 1987; 30(4):197-208. PubMed ID: 3501264
[TBL] [Abstract][Full Text] [Related]
17. Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value.
van de Kaa CA; Schijf CP; de Wilde PC; de Leeuw H; Gemmink JH; Robben JC; Vooijs PG
Mod Pathol; 1996 Oct; 9(10):1007-14. PubMed ID: 8902839
[TBL] [Abstract][Full Text] [Related]
18. The risk factors in the development of persistent trophoblastic disease following hydatidiform mole.
Tangtrakul S; Srisupundit S; Linasmita V; Bullangpoti S; Bhamarapravati Y
J Med Assoc Thai; 1990 Feb; 73 Suppl 1():33-6. PubMed ID: 2161897
[TBL] [Abstract][Full Text] [Related]
19. Origins of placental tumor found in DNA fingerprinting.
Oncology (Williston Park); 1991 Nov; 5(11):68. PubMed ID: 1837232
[No Abstract] [Full Text] [Related]
20. [Trophoblastic disease. II. Immunohistochemical and cytogenetic parameters of partial hydatidiform moles].
Danihel L; Porubský J; Vojtassák J; Breitenecker G
Cesk Patol; 1994 Aug; 30(3):80-4. PubMed ID: 7923421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
